132 related articles for article (PubMed ID: 24050129)
1. Animal models of Alzheimer's disease and drug development.
Laurijssens B; Aujard F; Rahman A
Drug Discov Today Technol; 2013 Sep; 10(3):e319-27. PubMed ID: 24050129
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic strategies and Alzheimer's disease: contribution of animal models].
Chabrier PE
Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893
[TBL] [Abstract][Full Text] [Related]
3. Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine.
Flood DG; Marek GJ; Williams M
Biochem Pharmacol; 2011 Jun; 81(12):1422-34. PubMed ID: 21295552
[TBL] [Abstract][Full Text] [Related]
4. Drug discovery in dementia: the role of rodent models.
Van Dam D; De Deyn PP
Nat Rev Drug Discov; 2006 Nov; 5(11):956-70. PubMed ID: 17080031
[TBL] [Abstract][Full Text] [Related]
5. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications.
Sabbagh JJ; Kinney JW; Cummings JL
Neurobiol Aging; 2013 Jan; 34(1):169-83. PubMed ID: 22464953
[TBL] [Abstract][Full Text] [Related]
6. New and emerging treatments for Alzheimer's disease.
Corbett A; Ballard C
Expert Opin Emerg Drugs; 2012 Jun; 17(2):147-56. PubMed ID: 22439621
[TBL] [Abstract][Full Text] [Related]
7. [The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].
de Jong D; Jansen RW; Verbeek MM; Kremer HP
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2074-8. PubMed ID: 12448960
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease modeling: ups, downs, and perspectives for human induced pluripotent stem cells.
Wojda U; Kuznicki J
J Alzheimers Dis; 2013; 34(3):563-88. PubMed ID: 23313930
[TBL] [Abstract][Full Text] [Related]
9. Is Alzheimer's a disease of the white matter?
Sachdev PS; Zhuang L; Braidy N; Wen W
Curr Opin Psychiatry; 2013 May; 26(3):244-51. PubMed ID: 23493128
[TBL] [Abstract][Full Text] [Related]
10. The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update.
Bales KR
Expert Opin Drug Discov; 2012 Apr; 7(4):281-97. PubMed ID: 22458501
[TBL] [Abstract][Full Text] [Related]
11. Preclinical models relevant to Tourette syndrome.
Swerdlow NR; Sutherland AN
Adv Neurol; 2006; 99():69-88. PubMed ID: 16536353
[TBL] [Abstract][Full Text] [Related]
12. Improving Alzheimer's disease phase II clinical trials.
Greenberg BD; Carrillo MC; Ryan JM; Gold M; Gallagher K; Grundman M; Berman RM; Ashwood T; Siemers ER
Alzheimers Dement; 2013 Jan; 9(1):39-49. PubMed ID: 23164548
[TBL] [Abstract][Full Text] [Related]
13. Searching for new animal models of Alzheimer's disease.
Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
[TBL] [Abstract][Full Text] [Related]
14. Invertebrate models of Alzheimer's disease.
Mhatre SD; Paddock BE; Saunders AJ; Marenda DR
J Alzheimers Dis; 2013; 33(1):3-16. PubMed ID: 22886023
[TBL] [Abstract][Full Text] [Related]
15. Transcranial electromagnetic treatment against Alzheimer's disease: why it has the potential to trump Alzheimer's disease drug development.
Arendash GW
J Alzheimers Dis; 2012; 32(2):243-66. PubMed ID: 22810103
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease--from cause to cure?
Vines G
Trends Biotechnol; 1993 Feb; 11(2):49-55. PubMed ID: 7763478
[TBL] [Abstract][Full Text] [Related]
17. Can herbs provide a new generation of drugs for treating Alzheimer's disease?
Anekonda TS; Reddy PH
Brain Res Brain Res Rev; 2005 Dec; 50(2):361-76. PubMed ID: 16263176
[TBL] [Abstract][Full Text] [Related]
18. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
Vasilevko V; Cribbs DH
Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's therapeutics: translation of preclinical science to clinical drug development.
Savonenko AV; Melnikova T; Hiatt A; Li T; Worley PF; Troncoso JC; Wong PC; Price DL
Neuropsychopharmacology; 2012 Jan; 37(1):261-77. PubMed ID: 21937983
[TBL] [Abstract][Full Text] [Related]
20. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
